212 related articles for article (PubMed ID: 22143059)
21. Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma.
Daudignon A; Poulain S; Morel P; Penther D; Parmentier F; Bouchindhomme B; Fernandes J; Duthilleul P; Bastard C
Leuk Res; 2010 May; 34(5):580-4. PubMed ID: 19959229
[TBL] [Abstract][Full Text] [Related]
22. Predicting clinical outcome in CLL: how and why.
Shanafelt TD
Hematology Am Soc Hematol Educ Program; 2009; ():421-9. PubMed ID: 20008228
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
[TBL] [Abstract][Full Text] [Related]
24. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia.
Sindelárová L; Michalová K; Zemanová Z; Ransdorfová S; Brezinová J; Peková S; Schwarz J; Karban J; Cmunt E
Cancer Genet Cytogenet; 2005 Jul; 160(1):27-34. PubMed ID: 15949567
[TBL] [Abstract][Full Text] [Related]
25. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
[TBL] [Abstract][Full Text] [Related]
26. Adverse prognostic features in chronic lymphocytic leukemia.
Mougalian SS; O'Brien S
Oncology (Williston Park); 2011 Jul; 25(8):692-6, 699. PubMed ID: 21874830
[TBL] [Abstract][Full Text] [Related]
27. Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.
Siddon AJ; Rinder HM;
Am J Clin Pathol; 2013 Jun; 139(6):708-12. PubMed ID: 23690112
[TBL] [Abstract][Full Text] [Related]
28. Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL).
Zenz T; Fröhling S; Mertens D; Döhner H; Stilgenbauer S
Best Pract Res Clin Haematol; 2010 Mar; 23(1):71-84. PubMed ID: 20620972
[TBL] [Abstract][Full Text] [Related]
29. Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice.
Doubek M; Mayer J; Obrtlíková P; Smolej L; Cmunt E; Schwarz J; Brejcha M; Kozmon P; Pospíšilová S; Brychtová Y; Pospíšil Z; Trněný M
Eur J Haematol; 2011 Aug; 87(2):130-7. PubMed ID: 21535162
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in chronic lymphocytic leukemia.
Hallek M; Kuhn-Hallek I; Emmerich B
Leukemia; 1997 Apr; 11 Suppl 2():S4-13. PubMed ID: 9178831
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
[TBL] [Abstract][Full Text] [Related]
32. Biological prognostic markers in chronic lymphocytic leukemia.
Vroblová V; Smolej L; Vrbacký F; Jankovicová K; Hrudková M; Malý J; Krejsek J
Acta Medica (Hradec Kralove); 2009; 52(1):3-8. PubMed ID: 19754000
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.
Grever MR; Lucas DM; Dewald GW; Neuberg DS; Reed JC; Kitada S; Flinn IW; Tallman MS; Appelbaum FR; Larson RA; Paietta E; Jelinek DF; Gribben JG; Byrd JC
J Clin Oncol; 2007 Mar; 25(7):799-804. PubMed ID: 17283363
[TBL] [Abstract][Full Text] [Related]
34. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia.
Sulda ML; Kuss BJ; Hall RK; Bailey S; Macardle PJ
Intern Med J; 2012 Feb; 42(2):137-46. PubMed ID: 20561095
[TBL] [Abstract][Full Text] [Related]
36. [Commentary on development of the prognostic factors concept in chronic lymphocytic leukaemia: the route from prognostic factors to therapy response predictors].
Balhárek T; Barthová M; Szépe P; Marcinek J; Burjanivová T; Plank L
Klin Onkol; 2009; 22(6):254-63. PubMed ID: 20099742
[TBL] [Abstract][Full Text] [Related]
37. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
[TBL] [Abstract][Full Text] [Related]
38. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
40. Chronic lymphocytic leukemia: staging and prognostic factors.
Zwiebel JA; Cheson BD
Semin Oncol; 1998 Feb; 25(1):42-59. PubMed ID: 9482526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
